Regulatory principles for biosimilar medicines

The science of biosimilarity: Immunogenicity

Introduction of the biosimilar trastuzumab and its impact on patients and services

Practical guidance on the assessment of biosimilar monoclonal antibodies: A physician's perspective

Impact of cancer prevention campaigns in Brazil: A google trends analysis

Public policy in the fight against non-communicable diseases

HPV: The global threat of vaccination hesitancy

Oncogenomics: From a surgical perspective

Symptomatic control in palliative medicine

Important developments in radiation oncology

New standard of care for lung cancer patients with EGFR mutations

Evaluating treatment options for acute myeloid leukaemia